2024-09-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
24.76% |
15.22% |
2024-08-29 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.03% |
-2.73% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
20.3% |
-0.17% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.37% |
6.04% |
2024-09-09 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.54% |
7.14% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.5% |
5.04% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.41% |
6.64% |
2024-09-05 |
The percentage of cash held in the portfolio is:
56.98%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
STAA |
Buy
All
|
0.59% |
Assets Rebalanced
None
2024-09-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
24.86% |
14.42% |
2024-08-29 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.03% |
-3.83% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
20.45% |
-0.5% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.24% |
3.45% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-6.11% |
3.06% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.84% |
3.06% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.77% |
1.45% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.72% |
2.37% |
2024-09-05 |
The percentage of cash held in the portfolio is:
63.86%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AADI |
Sell
All
|
7.43% |
TVTX |
Sell
All
|
48.65% |
Assets Rebalanced
None
2024-09-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
11.78% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
24.83% |
14.41% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.34% |
40.42% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.46% |
4.37% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
21.13% |
2.88% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.12% |
2.3% |
2024-09-09 |
STAA
STAAR Surgical Company
|
Sell |
-6.29% |
-0.03% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.44% |
9.69% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.91% |
-1.03% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.74% |
1.9% |
2024-09-05 |
The percentage of cash held in the portfolio is:
43.73%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CDMO |
Buy
All
|
-5.48% |
Assets Rebalanced
None
2024-09-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
11.88% |
1.14% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
25.09% |
12.73% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.04% |
31.25% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.13% |
-4.37% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
20.22% |
-3.99% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
8.95% |
-2.15% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-6.83% |
-5.48% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-5.97% |
7.41% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.47% |
11.39% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.89% |
1.88% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.8% |
3.32% |
2024-09-05 |
The percentage of cash held in the portfolio is:
51.67%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
AGEN |
Sell
All
|
8.41% |
Assets Rebalanced
None
2024-09-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AGEN
Agenus Inc.
|
Buy |
10.83% |
3.11% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.4% |
5.14% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
24.9% |
11.4% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
6.86% |
27.5% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.12% |
-4.92% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
20.18% |
-4.54% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
8.95% |
-2.56% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-6.51% |
-0.19% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.07% |
6.36% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.41% |
12.76% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.89% |
2.22% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.85% |
2.84% |
2024-09-05 |
The percentage of cash held in the portfolio is:
40.49%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
APLS |
Sell
All
|
-3.75% |
Assets Rebalanced
None
2024-09-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.35% |
-1.69% |
2024-08-22 |
AGEN
Agenus Inc.
|
Buy |
10.51% |
-0.18% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.02% |
1.71% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
24.81% |
10.8% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.21% |
33.75% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.1% |
-5.46% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
19.84% |
-6.37% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.23% |
0.26% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-6.46% |
0.85% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.05% |
6.89% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.29% |
14.88% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.86% |
2.99% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.87% |
2.84% |
2024-09-05 |
The percentage of cash held in the portfolio is:
30.45%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CARA |
Sell
All
|
-18.08% |
Assets Rebalanced
None
2024-09-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.45% |
0.21% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.43% |
-9.62% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.78% |
-6.22% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.11% |
3.43% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
23.78% |
7.2% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
7.16% |
33.96% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
4.96% |
-7.1% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
19.32% |
-7.98% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.17% |
0.63% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.46% |
15.41% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-5.97% |
7.17% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.39% |
12.41% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.23% |
12.56% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.73% |
4.27% |
2024-09-05 |
The percentage of cash held in the portfolio is:
21.62%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ALDX |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-09-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.85% |
3% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.89% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.54% |
-9.51% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.37% |
4.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
23.55% |
5.05% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
6.18% |
14.37% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
4.87% |
-9.84% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
20.59% |
-3.01% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
19.84% |
-6.48% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.21% |
0% |
2024-09-09 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.44% |
16.54% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.25% |
3.86% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.45% |
12.41% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-5.97% |
1.28% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.79% |
4.27% |
2024-09-05 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ORGO |
Sell
All
|
-12.72% |
Assets Rebalanced
None
2024-09-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.3% |
-1.42% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.75% |
-6.71% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.78% |
-6.41% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.55% |
-8.59% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.06% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
23.5% |
5.72% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
5.54% |
3.44% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.03% |
-6.01% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
21.04% |
0% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
21.03% |
0% |
2024-09-06 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.5% |
14.93% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.21% |
3.61% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.83% |
5.44% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-6.13% |
-2.31% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-5.91% |
1.42% |
2024-09-05 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.97% |
-5.21% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.03% |
-4.59% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.88% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.33% |
-11.33% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
12.15% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
23.27% |
3.96% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
5.64% |
4.69% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.36% |
-0.55% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
21.19% |
0% |
2024-09-05 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.69% |
12.67% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.31% |
2.72% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.93% |
4.42% |
2024-08-29 |
VREX
Varex Imaging Corporation
|
Sell |
-6.03% |
0% |
2024-09-05 |
CERS
Cerus Corporation
|
Sell |
-6.03% |
0% |
2024-09-05 |
The percentage of cash held in the portfolio is:
23.19%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CERS |
Sell
All
|
-11.34% |
EGRX |
Sell
All
|
-11.35% |
Assets Rebalanced
None
2024-09-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.25% |
-2.65% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.16% |
-3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.16% |
-3.5% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.53% |
-9.51% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
10.88% |
-7.98% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
11.75% |
-0.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
22.65% |
1.11% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
20.08% |
-10.38% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
5.4% |
0% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
5.4% |
0% |
2024-09-04 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.99% |
8.03% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.49% |
0.15% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.77% |
7.14% |
2024-08-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PINC |
Buy
All
|
-4.4% |
VERU |
Buy
All
|
-12.35% |
ARDX |
Sell
All
|
-11.62% |
NEOG |
Sell
All
|
-6.34% |
Assets Rebalanced
None
2024-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.64% |
-3.45% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.56% |
-4.2% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.33% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.36% |
3.79% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.33% |
-6.58% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
10.55% |
-5.88% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.76% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
15% |
-2.15% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
21.24% |
0% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
21.24% |
0% |
2024-08-29 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.97% |
3.4% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.07% |
1.42% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-6.18% |
-0.3% |
2024-08-28 |
AVXL
Anavex Life Sciences Corp.
|
Sell |
-5.89% |
0% |
2024-08-29 |
VERU
Veru Inc.
|
Sell |
-5.89% |
0% |
2024-08-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.54% |
-2.35% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.71% |
-0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.15% |
3.89% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.23% |
4.66% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.06% |
2.93% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
10.7% |
-2.52% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.53% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
15% |
0% |
2024-08-28 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.88% |
2.74% |
2024-08-26 |
STAA
STAAR Surgical Company
|
Sell |
-6.03% |
0% |
2024-08-28 |
PINC
Premier, Inc.
|
Sell |
-6.03% |
0% |
2024-08-28 |
The percentage of cash held in the portfolio is:
32.01%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.5% |
-0.94% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.58% |
-0.05% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.27% |
7.07% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.35% |
7.87% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.29% |
7.31% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
10.77% |
0% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.77% |
0% |
2024-08-27 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-5.81% |
2.08% |
2024-08-26 |
The percentage of cash held in the portfolio is:
34.3%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.66% |
-0.31% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.75% |
0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.03% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.84% |
1.46% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.28% |
6.03% |
2024-08-23 |
CDMO
Avid Bioservices, Inc.
|
Sell |
-6% |
0% |
2024-08-26 |
The percentage of cash held in the portfolio is:
56.43%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.4% |
-5.02% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.72% |
-1.79% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.61% |
-2.83% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.9% |
0% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.9% |
0% |
2024-08-23 |
The percentage of cash held in the portfolio is:
51.48%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
The percentage of cash held in the portfolio is:
70.6%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-21 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
EGRX |
Buy
All
|
3.38% |
Assets Rebalanced
None
2024-08-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.84% |
4.43% |
2024-07-31 |
The percentage of cash held in the portfolio is:
105.84%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
-1.57% |
Assets Rebalanced
None
2024-08-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
13.02% |
-2.95% |
2024-07-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.34% |
12.45% |
2024-07-31 |
The percentage of cash held in the portfolio is:
92.32%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PODD |
Buy
All
|
-2.48% |
Assets Rebalanced
None
2024-08-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
12.44% |
-7.66% |
2024-07-29 |
PODD
Insulet Corporation
|
Sell |
-6.37% |
2.34% |
2024-07-19 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.49% |
10.34% |
2024-07-31 |
The percentage of cash held in the portfolio is:
99.42%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RMD |
Sell
All
|
1.39% |
RCM |
Sell
All
|
7.14% |
Assets Rebalanced
None
2024-08-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
11.55% |
7.06% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
12.7% |
-5.3% |
2024-07-29 |
RMD
ResMed Inc.
|
Buy |
14.98% |
3.67% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-6.35% |
2.25% |
2024-07-19 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.61% |
8.02% |
2024-07-31 |
The percentage of cash held in the portfolio is:
72.73%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BKD |
Sell
All
|
-5.42% |
FATE |
Sell
All
|
7.71% |
Assets Rebalanced
None
2024-08-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BKD
Brookdale Senior Living Inc.
|
Buy |
7.8% |
-1.06% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
9.38% |
19.02% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
11.42% |
7.83% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
12.91% |
-1.96% |
2024-07-29 |
RMD
ResMed Inc.
|
Buy |
15.25% |
7.5% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-6.42% |
-0.76% |
2024-07-19 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.81% |
2.95% |
2024-07-31 |
The percentage of cash held in the portfolio is:
55.48%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
HQY |
Sell
All
|
-11.82% |
HCSG |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-08-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BKD
Brookdale Senior Living Inc.
|
Buy |
7.91% |
2.25% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
10.6% |
37.02% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
10.27% |
-1.15% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
13.35% |
3.34% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
12.52% |
-3.09% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
3.99% |
-1.12% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
14.27% |
2.5% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-6.24% |
0.31% |
2024-07-19 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.97% |
-1.69% |
2024-07-31 |
The percentage of cash held in the portfolio is:
39.29%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
OPK |
Sell
All
|
7.58% |
PDSB |
Sell
All
|
1.14% |
Assets Rebalanced
None
2024-07-31 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
13.34% |
8.33% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.08% |
-1.7% |
2024-07-11 |
BKD
Brookdale Senior Living Inc.
|
Buy |
8.08% |
3.44% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
10.3% |
31.88% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
10.39% |
-1% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
13.23% |
1.38% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
12.63% |
-3.16% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
4.05% |
-0.43% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
14.06% |
0% |
2024-07-31 |
PODD
Insulet Corporation
|
Sell |
-6.28% |
0.6% |
2024-07-19 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Sell |
-5.93% |
0% |
2024-07-31 |
The percentage of cash held in the portfolio is:
16.06%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMTI |
Sell
All
|
-8.69% |
CLDX |
Sell
All
|
-12.36% |
Assets Rebalanced
None
2024-07-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
12.92% |
8.33% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.78% |
8.52% |
2024-07-11 |
BKD
Brookdale Senior Living Inc.
|
Buy |
7.9% |
4.37% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
10.52% |
39.07% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
9.9% |
-2.61% |
2024-07-18 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
10.8% |
-4.26% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
11.95% |
-5.45% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
12.87% |
1.77% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
12.43% |
-1.69% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
3.94% |
0% |
2024-07-30 |
PODD
Insulet Corporation
|
Sell |
-6.02% |
1.61% |
2024-07-19 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
RMD |
Buy
All
|
-5.84% |
PTGX |
Sell
All
|
-7.35% |
Assets Rebalanced
None
2024-07-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
12.98% |
12.12% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.63% |
10.23% |
2024-07-11 |
BKD
Brookdale Senior Living Inc.
|
Buy |
7.76% |
5.69% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
10.27% |
39.85% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
9.85% |
-0.19% |
2024-07-18 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
10.53% |
-3.84% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
11.12% |
1.6% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
12.26% |
0% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
12.26% |
0% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
12.26% |
0% |
2024-07-29 |
PODD
Insulet Corporation
|
Sell |
-5.89% |
0.85% |
2024-07-19 |
RMD
ResMed Inc.
|
Sell |
-6.03% |
0% |
2024-07-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ATRC |
Sell
All
|
-12.65% |
Assets Rebalanced
None
2024-07-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
12.43% |
7.58% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.77% |
11.93% |
2024-07-11 |
BKD
Brookdale Senior Living Inc.
|
Buy |
7.58% |
3.44% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
10.18% |
38.82% |
2024-07-16 |
ATRC
AtriCure, Inc.
|
Buy |
9.43% |
-7% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
9.77% |
-0.84% |
2024-07-18 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
10.85% |
-0.76% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
10.93% |
0% |
2024-07-26 |
PODD
Insulet Corporation
|
Sell |
-5.81% |
2.09% |
2024-07-19 |
The percentage of cash held in the portfolio is:
23.86%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
12.5% |
7.58% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.35% |
6.96% |
2024-07-11 |
BKD
Brookdale Senior Living Inc.
|
Buy |
7.64% |
3.7% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
9.81% |
33.16% |
2024-07-16 |
ATRC
AtriCure, Inc.
|
Buy |
9.66% |
-5.18% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
9.99% |
0.92% |
2024-07-18 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
10.99% |
0% |
2024-07-25 |
PODD
Insulet Corporation
|
Sell |
-5.94% |
0.3% |
2024-07-19 |
The percentage of cash held in the portfolio is:
34.98%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
12.91% |
10.61% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.77% |
10.8% |
2024-07-11 |
BKD
Brookdale Senior Living Inc.
|
Buy |
7.61% |
2.78% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.68% |
17.22% |
2024-07-16 |
ATRC
AtriCure, Inc.
|
Buy |
9.64% |
-5.85% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
10.16% |
2.15% |
2024-07-18 |
PODD
Insulet Corporation
|
Sell |
-5.97% |
0.37% |
2024-07-19 |
The percentage of cash held in the portfolio is:
46.19%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VRDN |
Sell
All
|
13.4% |
Assets Rebalanced
None
2024-07-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
11.86% |
9.54% |
2024-07-02 |
OPK
OPKO Health, Inc.
|
Buy |
13.28% |
12.88% |
2024-07-11 |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.78% |
9.94% |
2024-07-11 |
BKD
Brookdale Senior Living Inc.
|
Buy |
7.55% |
1.19% |
2024-07-16 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.19% |
9.77% |
2024-07-16 |
ATRC
AtriCure, Inc.
|
Buy |
9.86% |
-4.47% |
2024-07-17 |
RCM
R1 RCM Inc.
|
Buy |
10.23% |
2% |
2024-07-18 |
PODD
Insulet Corporation
|
Sell |
-6.04% |
-0.04% |
2024-07-19 |
The percentage of cash held in the portfolio is:
34.28%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ALT |
Sell
All
|
-16.04% |
Assets Rebalanced
None